Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Continuing at fiscal 2007 level

This article was originally published in The Tan Sheet

Executive Summary

FDA and other federal agencies will operate under fiscal 2007 appropriation levels through Nov. 16, according to a continuing resolution passed by Congress on Sept. 27. With no fiscal 2008 appropriations approved by either chamber of Congress as the end of the federal fiscal year approached, House Appropriations Committee Chairman David Obey, D-Wis., on Sept. 25 introduced H. Res. 52 to continue funding government for six weeks. The spending directive for each federal agency would be replaced by its fiscal 2008 appropriation prior to Nov. 16 in the event Congress enacts the legislation before that date, according to H. Res. 52. Like other federal agencies not within the departments of Defense and Homeland Security, FDA's entire fiscal 2007 budget was included in a continuing resolution Congress enacted in February after failing to agree on fiscal 2008 spending levels in separate bills covering the traditional grouping of agencies (1"The Tan Sheet" Feb. 19, 2007, p. 14). House Appropriations Agriculture Subcommittee Chairwoman Rosa DeLauro, D-Conn., in March said the Bush administration's fiscal 2008 budget request for FDA did not reflect the agency's needs (2"The Tan Sheet" March 5. 2007, p. 18)...
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS100949

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel